Theriva Biologics Insider Trades
NYSE: TOVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Theriva Biologics insider activity
No Theriva Biologics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows SHALLCROSS STEVEN A (CEO and CFO) buying 14,000 shares at $0.6931 on Jun 7, 2023. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TOVX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TOVX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 7, 2023 | SHALLCROSS STEVEN ACEO and CFO | Buy | 14,000 | $9.70K | Form 4 |
| Jun 6, 2023 | SHALLCROSS STEVEN ACEO and CFO | Buy | 26,000 | $16.45K | Form 4 |
| Feb 10, 2023 | SHALLCROSS STEVEN ACEO and CFO | Buy | 25,000 | $26.07K | Form 4 |
| Feb 2, 2023 | SHALLCROSS STEVEN ACEO and CFO | Buy | 25,000 | $23.51K | Form 4 |
| Jan 25, 2023 | SHALLCROSS STEVEN ACEO and CFO | Buy | 25,000 | $21.82K | Form 4 |
| Jan 20, 2023 | SHALLCROSS STEVEN ACEO and CFO | Buy | 25,000 | $18.70K | Form 4 |
| Dec 29, 2022 | SHALLCROSS STEVEN ACEO and CFO | Buy | 100,000 | $43.70K | Form 4 |
| May 10, 2021 | SHALLCROSS STEVEN ACEO and CFO | Buy | 50,000 | $24.59K | Form 4 |
| Aug 23, 2019 | SHALLCROSS STEVEN ACEO and CFO | Buy | 50,000 | $20.79K | Form 4 |
| Apr 3, 2019 | KIRK RANDAL J & INTREXON CORP10% Owner | Sale | 69,161 | $44.95K | Form 4 |
| Apr 3, 2019 | KIRK RANDAL J & INTREXON CORP10% Owner | Sale | 26,080 | $16.95K | Form 4 |
| Apr 2, 2019 | KIRK RANDAL J & INTREXON CORP10% Owner | Sale | 9,909 | $6.54K | Form 4 |
| Apr 2, 2019 | KIRK RANDAL J & INTREXON CORP10% Owner | Sale | 3,737 | $2.47K | Form 4 |
| Apr 1, 2019 | KIRK RANDAL J & INTREXON CORP10% Owner | Sale | 30,265 | $20.28K | Form 4 |
| Apr 1, 2019 | KIRK RANDAL J & INTREXON CORP10% Owner | Sale | 11,413 | $7.65K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4